Japan just classified XRP under the same legal framework as stocks and bonds. Pension funds. Insurance companies. Regulated asset managers. All of them were lJapan just classified XRP under the same legal framework as stocks and bonds. Pension funds. Insurance companies. Regulated asset managers. All of them were l
Japan classifies XRP like stocks, enabling access for pension funds, insurance companies, and regulated asset managers by Q2 2026.
For feedback or concerns regarding this content, please contact us at [email protected]
Japan just classified XRP under the same legal framework as stocks and bonds. Pension funds. Insurance companies. Regulated asset managers. All of them were locked out before. Q2 2026 changes that.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Nigeria invests $9m in research to drive digital economy ambitions
Nigeria has committed $9 million (₦12 billion) to a new national research initiative aimed at strengthening evidence-based policymaking
Share
Techcabal2026/04/02 18:17
Why MTN, Airtel, Glo, others are resuming voice and data lending services after a 5-week suspension
Five weeks after Nigerian mobile network operators (MNOs) announced the suspension of voice and data lending services (XtraTime),…
Share
Technext2026/05/29 23:55
Tempus AI (TEM) Stock: Plunge as FDA Clears xT CDx Tumor-Only Cancer Test
TLDR Tempus AI stock drops 1.66% despite FDA approval for xT CDx test TEM rally fades after FDA clears tumor-only cancer profiling test Tempus secures FDA nod for
Share
Coincentral2026/05/30 00:33
